Conclusion The results of this this study indicate that the LBM combination can be used as a therapeutic for ameliorating NAFLD via modulating the gut microbiota and improving insulin resistance
The protocol enrolled 670 adults who completed 36 weeks of open-label tirzepatide (achieving a mean weight loss of 20.9%), then randomised them to either continue tirzepatide or switch to placebo for another 52 weeks
Three months might feel like a long time when youre eager for results, but its actually just the beginning of your Zepbound journey
Patients often experience significant reductions in their blood sugar levels, which can reduce the risk of diabetes-related complications such as cardiovascular disease, kidney problems, and neuropathy
People on GLP-1 receptor agonists often describe not just feeling less hungry, but genuinely caring less about food
The same dopamine suppression that quiets cravings might flatten mood, reduce motivation, or delete the capacity for joy in someone already prone to depression